Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, signaling strong market confidence and positive business fundamentals [1] Group 1: Share Repurchase Activity - On February 5, Yidu Tech announced a share repurchase, buying approximately 1.88 million shares at around HKD 5.55 per share, totaling over HKD 10 million [1] - This marks the ninth consecutive trading day of intensive repurchases, with a cumulative expenditure of approximately HKD 44 million [1] - The daily repurchase amount continues to maintain a high level, reflecting the company's commitment to enhancing shareholder value [1] Group 2: Capital Inflows - Southbound funds have shown consistent interest in Yidu Tech, with net purchases for nine consecutive days, totaling HKD 44.97 million as of February 2 [1] - As of February 2, southbound funds held approximately 237 million shares of the company, representing 22.14% of total shares, with a market value of about HKD 1.333 billion [1] - The combination of the company's share repurchase and the inflow of southbound funds sends a positive signal to the market [1] Group 3: Business Fundamentals - The positive capital movements align with the company's recent business developments, including partnerships for "AI + health management" with Shenzhen Nanshan Hospital and the launch of a general medicine AI assistant with Chongqing Medical University First Affiliated Hospital [1] - The ongoing share repurchase and capital inflow reflect market recognition of the company's business value and strategic execution capabilities [1]
医渡科技(02158)九连回购单日再破千万 南向资金同步持续加仓